Manhattan Scientifics announces FDA approval for new titanium dental implant

This clearance positions the company closer to its goal of commercializing its technology and increasing shareholder value, said Manhattan Scientifics.

This patented new form of titanium metal originally developed by Russian scientists in concert with scientists at the Los Alamos National Laboratory is expected to significantly improve dental implants.

Studies have shown that bone integrates with these new metals up to 20 times faster than with conventional metals. Patients should experience shorter post surgery healing times and a more reliable integration of these new implants into their body, the company said.

Manhattan Scientifics anticipates developing additional products based on this new titanium metal for use in orthopedics and stents.

Terry Lowe, chief scientist at Manhattan Scientifics, said: “The $2 billion annual dental implant wholesale market is 10% the size of the market for other medical devices (for example hips, spinal devices and cardiovascular stents) that can benefit from the advantages of our advanced metals.”